Navigation Links
Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign
Date:4/24/2013

NEW YORK, April 25, 2013 /PRNewswire-USNewswire/ -- Malaria No More announced today, World Malaria Day, that some of the world's most innovative companies have signed on for the Power of One campaign, which will use the latest social, mobile, and e-commerce technologies to rally the global public to close malaria testing and treatment gaps in Africa.

A child dies every minute from malaria, making it one of the top killers of children worldwide. Every dollar donated to the Power of One campaign will fund a full course of life-saving treatment for each child diagnosed with a case of malaria. The campaign aims to accelerate progress in malaria and close the Africa treatment gap, of approximately 436 million treatments, between now and the end of 2015. This will be achieved through direct donations that complement existing government commitments along with efforts to increase both public and private investment in the fight against malaria. Power of One will launch to the public in the fall.

Power of One is supported by significant commitments from Novartis (NYSE: NVS), the world's leading provider of malaria treatments, and Alere Inc. (NYSE: ALR), the world's leading provider of rapid diagnostic tests for several chronic and infectious diseases, including malaria. Through the partnership, Novartis will donate up to three million full courses of its pediatric antimalaria drug and will support the campaign financially over the next three years. Alere will donate two million rapid diagnostic tests over the next two years to accurately diagnose the disease in sub-Saharan Africa.

"We believe that this innovative campaign will help speed malaria elimination," said Joseph Jimenez , Novartis Chief Executive Officer. "Novartis has been striving towards this goal for more than a decade, and we just reached the milestone of providing 600 million treatments without profit to patients in malaria-endemic countries. No one should die from malaria today."

"We are very excited to support the Power of One campaign and play a leading role in combating one of the world's most dangerous infectious diseases," said Alere CEO, Ron Zwanziger . "Reliable diagnostics are critical to the achievement of this goal, enabling health workers to identify cases of malaria within a matter of minutes and ensuring that therapy is appropriately targeted.  Alere's mission is to improve individual health outcomes on a worldwide scale, and this partnership with Malaria No More provides one example of how we're able to accomplish that."

Power of One is the result of collaboration between Malaria No More, a nonprofit organization, and West, a marketing strategy and creative group founded by former Apple marketing executive Allison Johnson . Havas Worldwide (NYSE: HAVS) has signed on to help lead creative development and production, and Blue State Digital, a recognized leader in online fundraising, advocacy, social networking, and constituency engagement is applying lessons from the Obama campaign to this global grassroots issue.

Malaria No More CEO Martin Edlund said, "The Power of One campaign has the potential to revolutionize the way the consumer public and corporations engage with global issues. We are extremely proud to welcome Novartis, Alere and the other forward-thinking corporate and media partners who have signed on to help us end malaria deaths one dollar and one child at a time."

Additional campaign partners include media leaders Time Warner Inc. (NYSE: TWX) and News Corporation, who will contribute in-kind media placement, and Home Box Office, Inc. (HBO), which lent its new film MARY AND MARTHA to an innovative opportunity to contribute malaria treatments. For every video view of HBO Films' MARY AND MARTHA trailer today, World Malaria Day, Malaria No More will provide a full course of treatment for a child with malaria up to 50,000 treatments. The film, which began airing on HBO on April 20th, tells the story of two mothers who lose children to malaria.

The Power of One also brings in technology innovator Twitter. Their contributions to the initiative will be announced later this year. The campaign is receiving additional financial support from Newman's Own Foundation.

For more information about the Power of One campaign, visit www.Po1.org.

About Malaria No More
Malaria No More is determined to end malaria deaths. We're helping the world get it done by engaging leaders, rallying the public, and delivering life-saving tools and education to families across Africa. Founded in 2006 by business leaders Ray Chambers and Peter Chernin , Malaria No More is working to create a world in which no one dies from a mosquito bite. For more information, visit www.MalariaNoMore.org.

About Power of One
Power of One will offer the global public and corporations the opportunity to help end malaria deaths one dollar and one child at a time. Every dollar donated will fund a full course of life-saving treatment for each child diagnosed with a case of malaria. Malaria No More is grateful for the support and contributions of Power of One corporate partners including Novartis, Alere, News Corporation, Time Warner, Twitter, and more. Additional information is available at www.Po1.org.

Press Contacts:
Erica Lichtenberger
Malaria No More
212-710-5891
erica@malarianomore.org

Cristin Klein
Sunshine Sachs
212-691-2800
klein@sunshinesachs.com


'/>"/>
SOURCE Malaria No More
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Whats Next In Vaccines (Malaria, Diabetes, Alzheimers, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)
2. New Research Reveals Extent of Poor-Quality Antimalarial Medicines in South American Countries
3. Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria
4. Sigma-taus Antimalarial Awarded "Project of the Year" 2011 by Medicines for Malaria Venture
5. Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resistance
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 10, 2016 CERS ), Medivation, Inc. ... ) and Celldex Therapeutics, Inc. (NASDAQ: CLDX ). ... Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS ) and Celldex Therapeutics, ... Orphan Drug Designations become vitally important in the development of ... drugs and biologics which are defined as those intended for ...
(Date:2/10/2016)... /PRNewswire/ - The President of New Venture Medical, ... an anti-radiation product from their Research and Development ... treatment of cancer using radiation and the treating ... the healing of radiation burns, even when open ... the healthy cells from radiation damage. It selectively ...
(Date:2/10/2016)... , Feb. 10, 2016  Silicon Biosystems Menarini ... products that help uncover the biological complexities of ... Inc., a developer of innovative technologies for genomics ... partnership aimed at enabling translational researchers to obtain ... couple hundred tumor and normal cells in an ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... 10, 2016 , ... Everseat has joined the award-winning Allscripts ... physicians. The integration will enable Allscripts users to post open appointments to the ... app. , The partnership gives Everseat substantial added power to help Allscripts meet ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics this week announced the launch ... mounts ever. , “Our goal was to develop a product from the ground ... we have ever created.” said Darren Hulsey, Product Manager for Workrite Ergonomics. “The ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Anxiety of older ... the start of Medicare Part D a decade ago, according to The Senior ... older adults on how they are coping with rapidly rising costs. “The implications ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Face and Body Specialists are delighted to welcome a new addition to their ... Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
(Date:2/10/2016)... ... February 10, 2016 , ... It’s that time of year when most ... of the Interscholastic Athletic Association of Maryland (IAAM), Hall of Fame athlete and Garrison ... are cast aside. , That’s why one of her first decisions when her IAAM ...
Breaking Medicine News(10 mins):